Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
J01FF01
|
| gptkbp:availableOn |
capsule
injection topical solution |
| gptkbp:brand |
gptkb:clindamycin
|
| gptkbp:contraindication |
hypersensitivity to clindamycin
|
| gptkbp:discoveredIn |
1960s
|
| gptkbp:drugClass |
lincosamide
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dalacin
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
inhibits bacterial protein synthesis
|
| gptkbp:pregnancyCategory |
B (US)
B (Australia) |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
topical intravenous |
| gptkbp:sideEffect |
nausea
diarrhea rash |
| gptkbp:usedFor |
skin infections
acne pelvic inflammatory disease bacterial infections respiratory tract infections dental infections bone and joint infections |
| gptkbp:bfsParent |
gptkb:Clindamycin
gptkb:clindamycin |
| gptkbp:bfsLayer |
7
|